VERTEX PHARMACEUTICALS INC (VRTX) Stock Forecast & Price Prediction

Data as of 2026-10-26 · VRTX trades at $521.03 (+0.68% today) · Health Care sector.

Q-Score

68/100

Grade A — "Strong Buy" composite of 140+ signals

Analyst Target

$565.81

5 targets · $553.25–$578.56 · implied +8.6%

EPS Estimate

$4.88

Next period consensus (2026-12-31) · 12 analysts · revenue $3.5B

Next Earnings

2026-11-02

in 5 days — expect volatility

What Wall Street is saying about VRTX

Across 5 price targets published in the last 90 days (latest 2026-09-04), the consensus for VERTEX PHARMACEUTICALS INC is $565.81 — spanning $553.25 on the low end to $578.56 on the high end.

Next-period consensus (fiscal period 2026-12-31): EPS $4.88 (range $4.27–$5.40) on revenue of $3.5B, from 12 analysts.

Track record — don't trust a forecast without one

StoQuant publishes its full walk-forward accuracy, updated daily. Current hit rates across all scored signals:

Signal	Window	Hit rate	Avg return	Observations
Fundamental Undervalue	7d	50.6%	+0.45%	9,620
Volume Spike	7d	48.8%	+0.19%	6,449
Sector Momentum	7d	48.6%	+0.03%	16,414
Bollinger Squeeze	7d	46.8%	-0.17%	8,985

See the full live track record → · How the model works

⚠ VERTEX PHARMACEUTICALS INC reports earnings on 2026-11-02 — expect elevated volatility and a forecast refresh right after the report.

Peers & alternatives

Similar stocks to VRTX for comparison and diversification research:

AZN research NVS research NVO research SNY research GSK research

Compare VRTX vs AZN head-to-head →

More forecasts to explore

AAPL MSFT NVDA GOOGL GOOG AMZN META TSLA AVGO LLY JPM V WMT XOM UNH MA COST ORCL HD NFLX

Explore more forecasts

Discover other stocks and tools:

All forecasts Free screener Full VRTX research Proof & methodology

VRTX forecast FAQ

Is VRTX stock a buy or sell right now?

StoQuant's Q-Score rates VRTX 68/100 (grade A, "Strong Buy"). StoQuant publishes its full walk-forward track record at /proof — always check a forecaster's accuracy before acting.

What is the analyst price target for VRTX?

The consensus analyst price target for VERTEX PHARMACEUTICALS INC is $565.81, with a range of $553.25 to $578.56 across 5 recent analyst targets — an implied +8.6% move from the current price of $521.03.

How accurate are StoQuant's stock forecasts?

Across StoQuant's walk-forward validated signal history, the fundamental undervalue signal hit its 7-day target in 50.6% of 9,620 observations (avg return +0.45%). Full methodology and live accuracy at /proof.

When does VRTX report earnings?

VERTEX PHARMACEUTICALS INC is scheduled to report earnings on 2026-11-02. Expect elevated forecast volatility around the report.

More stock forecasts in this sector

Technology sector forecasts

MSFT · AAPL · NVDA · GOOGL · META · TSLA · AMD · INTC · QCOM · AVGO

Large-cap diversified forecasts

BRK.B · JPM · V · MA · WMT · PG · JNJ · XOM · UNH · HD

Consumer and healthcare forecasts

COST · MCD · NFLX · DIS · PFE · ABBV · TMO · CRM · ADBE

Financial and energy forecasts

BAC · WFC · GS · MS · CVX · COP · UBER · AMAT · MU

Unlock VRTX's forecast, fair value, insider detail & signals.

ML forecasts, Q-Scores, insider clusters, and catalysts across 4,000+ tickers. Free to start.

Register founding interest — Pro $29/mo or Power $79/mo

Paid plans aren’t for sale yet. Leave your email to lock founding pricing (Pro $29, Power $79); we’ll reach out personally.

Additional resources

Track record · Methodology · All forecasts · VRTX deep dive

Forecasts are probabilistic model outputs, not investment advice. Past accuracy does not guarantee future results.